Trials / Completed
CompletedNCT02756624
A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 516 (actual)
- Sponsor
- Nicox Ophthalmics, Inc. · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
This is study is evaluating the safety and tolerability of AC-170 Ophthalmic Solution
Detailed description
Central Cornea Endothelial Cell Counts will be done on a subset of approximately 150 subjects to complete 100 subjects as part of the safety measures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AC-170 0.24% | |
| DRUG | AC-170 Vehicle |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2016-04-29
- Last updated
- 2017-09-11
- Results posted
- 2017-07-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02756624. Inclusion in this directory is not an endorsement.